Back to News
Market Impact: 0.2
JP Morgan Initiates Coverage of Praxis Precision Medicines at Overweight
Source: Nasdaq
Analyst Insights
JPMorgan initiated coverage of Praxis Precision Medicines on October 16, 2026, with an Overweight recommendation. Praxis closed at $241.78 that day, versus $248.24 on October 15; the article text is truncated before completing its description of the price change.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
PRAX0.55
More News
- SCHD Is Crushing the Vanguard High Dividend Yield ETF (VYM) This Year. I Predict That Advantage Is About to Fade.
- Don’t Let a Crypto Inheritance Get Stuck on the Blockchain
- Get Help With Holiday Spending: Best Credit Card Bonuses This Week, Oct. 17, 2026
- These tech stocks are a buy ahead of their earnings reports, Bank of America says
- Citi says interest rates may matter more for economy than stock valuations
- AI Selloff Tests Investor Confidence